NotizieAssistito da IA

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification

Marksans Pharma's Goa facility receives EIR from USFDA, inspection classified as VAI.

Di Mrudula Kulkarni

Caporedattore - Pharma Now

21 ago 2024Updated Jun 26, 2025 · 2 min di lettura

Condividi Aggiungi come fonte preferita

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification — https://www.marksanspharma.com/

Giornalismo assistito da IA

Reviewed by Mrudula Kulkarni, Caporedattore - Pharma Now

For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).

ArgomentiNotizie

Written by

Mrudula Kulkarni

Caporedattore - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.